A pre-deposit autologous blood transfusion service for elective surgical patients is described and recommended.
The use of banked autologous blood for transfusion in elective surgery avoids many of the problems associated with homologous or donor blood. This paper questions the present accepted technique of using donor blood for elective surgery and describes the setcing up and implementation of the predeposit autologous blood programme in the Whyalla Hospital. This hospital has 240 beds and is the Base Hospital for the northern region of South Australia, an enormous area of more than 800,000 square kilometres. Scattered throughout this region are 100,000 people and this includes Whyalla's population of about 32,000. DEVELOPMENT The autologous blood programme was initiated following discussions between hospital and transfusion administrators. To ensure the success of the programme talks were also held with all local doctors, nursing staff of both the Whyalla Hospital and the doctor's private surgeries, laboratory staff and operating theatre booking clerks. Before introducing any new blood therapy approach into a hospital, it must be understood and accepted by both the medical and nursing staff.
METHOD
There are three techniques of autologous blood transfusion:-1. Preoperative collection and storage.
2. Acute perioperative collection and haemodilution. 3. Intraoperative scavenging. At Whyalla, the first of these, a preoperative collection and storage programme was implemented. More recently, on selected patients, the second method of acute perioperative collection and haemodilution with dextran 70 (Macrodex) has been used.
All patients are treated as Australian Red Cross Blood Donors. The service is free to the patient. Blood is not taken from patients whose Haemoglobin is less that 12 g/ 100 ml or 12.5 g/ 1 00 ml for females and males respectively. The standard Red Cross technique and equipment is used for phlebotomy. This service is provided by a registered nurse, a laboratory technician and an anaesthetist. An anaesthetic history and a red cross blood donor history are taken. The Red Cross enrolment form was noted "Autologous Blood" and sent to the laboratory with a specimen of the patient's blood. This is processed urgently, so that if the autologous blood is not used, it then becomes donor blood.
PREOPERATIVE MEDICAL CHECK
Patients are weighed, their blood pressure measured and their haemoglobin checked. They receive a general medical examination and if indicated investigations include E.c.G. and chest X-Ray. The following additional blood tests are performed:-I. Grouping -A.B.O., Rh and Kell. 2. Serology for hepatitis B and syphilis. 3. Screen for atypical antibodies.
PHLEBOTOMY
Most patients have two units of blood taken (each of 450 ml of blood and 65 ml of anticoagulant) generally a week apart. The first unit is taken ten days before operation, and the second unit three days before operation. Following phlebotomy all patients are given oral iron therapy. The autologous blood is stored in a separate compartment of the hospital blood refrigerator.
AUTOLOGOUS BLOOD LABEL
The autologous blood is labeIled with the Red Cross transfusion number and an Autologous Blood label. This label was designed to be simple, legible and easy to check.
Transfusion tragedies are more commonly due to clerical error than to technical error. The Safety of this Autologous Blood Programme is based on the patient signing the label on his own packet of blood and signing an identical label in his case notes.
RESULTS
Data from the first 135 cases have been reviewed (Tables 2 and 3 ). (1) Average: 950 ml.
(2) Range: 100 ml-3,400 ml. Type of Operation:
Orthopaedics -70 cases. General Surgical -39 cases.
Gynaecological -26 cases.
The majority of patients underwent a major orthopaedic procedure. During this period no major elective paediatric surgery was performed. A 34 year old female donated two units of blood over ten days and her haemoglobin dropped from 13.4 g/lOO ml to 9.7 g/lOO ml. Postoperatively, patients had their haemoglobin checked at 48 hours and it was greater than 10 g/lOO ml in all but nine cases. Two patients, a male and a female, had a haemoglobin level of 7.2 g/ 1 00 ml following posterior spinal fusion operations. Autologous blood is better matched and safer than the best possible donor blood. On immunological grounds alone, autologous bloed should be recommended. There is no immunization to foreign blood components. The risk of transmitted infection, particularly hepatitis is removed. Autologous blood used in this service, even if it is ten days old, is significantly fresher than the alternative donor bJOod. Our Transfusion Services estimate that 10% or more of patients receiving donor blood suffer some unfavourable side effect or reaction and immune antibodies develop in 1 %. No blood transfusion reaction has occurred in patients receiving autologous blood.
DISCUSSION

Non Blood Benefits for the Patient
The well timed preoperative medical check ten days before operation has a number of evident advantages. More meaningful history, examination and investigations can be carried out and there is time to properly prepare patients for anaesthesia and surgery.
Benefits for the Transfusion Service
1. An informed Blood Bank. 2. Donor blood is spared. 3. Unused autologous blood becomes donor blood.
4. Increased Red Cross blood donor recruitment. There is time for the Blood Bank to plan its blood needs. The Blood Bank, armed with early notification of the patient's blood group, the type of operation to be performed and the date of the patient's operation, can more objectively calculate its requirements of Donor Blood.
The patient himself represents a matched, safe source of blood. Donor blood is spared for emergencies. Autologous blood not used becomes donor blood. We estimate that 25 % of autologous blood donors will become future Red Cross blood donors.
The Red Cross Blood Transfusion Services for the Northern Region of South Australia are based in Whyalla, and during the period 1st July, 1977 to 13th December, 1977 some 1,481 units of blood were donated. The amount of blood used during this period was 569 units.
It is estimated that 85 % of this blood was needed for surgical patients; probably more than 70% was used for elective surgery.
In remote communities, the supply of donor blood presents special difficulties and there is significant wastage. This problem can largely be overcome by using autologous blood.
In country areas there are considerable cost advantages in using autologous blood. The service is provided by existing staff who are paid irrespective of whether the scheme is operating or not and transport costs are eliminated.
Problems of using Autologous Blood
A. For the Patient 1. Anaemia 2. Hypovolaemia 3. Fainting 4. Loss of working time. 5. Recipient identification, pack labelling and storage. Most of these problems are overcome by appropriate staff including, a registered nurse, a laboratory technician and an anaesthetist. The possibility of a clerical error in providing the wrong blood for the patient still remains.
On no occasion has preoperative anaemia been a problem. There is no accepted safe preoperative, operative or postoperative haemoglobin level. However, recent clinical work, experimental evidence and considerable medical literature (Rawstron 1976 ) support the present author's belief that a haemoglobin level of 10 g/lOO ml of blood is safe for major surgery. Nevertheless, it is essential that blood loss, blood volume and haemoglobin be carefully monitored.
No evidence of hypovolaemia, such as hypotension, tachycardia or poor urine output has been found. Autologous blood is particularly useful for patients who have auto antibodies or preformed immune alloantibodies from previous transfusions or pregnancies. An Autologous Blood Service is most useful for communities of less than 100,000 people. The smaller and more isolated the community the greater the benefit. It is recommended that autologous blood be used for patients with histories of previous blood transfusion reactions. Patients who on religious grounds refuse donor blood, occasionally accept autologous blood.
Clearly, autologous blood is strongly indicated for selected patients. To cater for these patients all communities with blood bank facilities should develop autologous blood programmes. Having established the need for an autologous blood programme, it seems logical that all patients undergoing major surgery should be offered its services.
In summary, it is recommended that autologous blood should be used for transfusion during elective surgical operations. It offers real therapeutic and immunological advantages over donor blood. Blood is a commodity of which there is a limited supply and autologous blood would help cater for our increasing needs. The preoperative collection and storage of a patient's blood for autologous transfusion is economic, safe and is good medicine.
